XML 44 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Income - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Profit or loss [abstract]      
Revenue $ 1,634,393 $ 1,591,601 $ 1,364,146
Cost of goods sold (1,217,738) (1,228,112) (1,142,880)
Gross profit 416,655 363,489 221,266
Selling expense (33,623) (31,009) (29,938)
General and administrative expense (128,930) (99,909) (87,513)
Net impairment losses on financial assets (398) (1,224) (3,711)
Fair value loss on sale of accounts receivable, net (4,620) (6,113) (3,041)
Other operating income/(loss), net 2,304 402 (21)
Operating income 251,388 225,636 97,042
Finance cost, net (26,175) (22,244) (19,078)
Income from associate 0 0 272
Foreign exchange gain/(loss), net 20,846 (11,981) 19,990
Derivative financial instrument (loss)/gain, net (22,441) 10,967 (18,534)
Income before income taxes 223,618 202,378 79,692
Income tax expense (57,544) (47,134) (16,971)
Net income $ 166,074 $ 155,244 $ 62,721
Earnings per share of common stock:      
Basic earnings per share (in usd per share) $ 0.95 $ 0.89 $ 0.36
Diluted earnings per share (in usd per share) $ 0.95 $ 0.89 $ 0.36
Weighted average number of common stock - basic (in shares) 175,362,465 175,362,465 175,362,465
Weighted average number of common stock - diluted (in shares) 175,362,465 175,362,465 175,362,465